Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Drug Therapy | 2 |
| Hyperactivity | 2 |
| Physiology | 2 |
| Adolescents | 1 |
| Behavior Disorders | 1 |
| Behavior Problems | 1 |
| Body Weight | 1 |
| Check Lists | 1 |
| Child Behavior | 1 |
| Children | 1 |
| Cognitive Ability | 1 |
| More ▼ | |
Author
| Aman, Michael G. | 1 |
| Arnold, L. Eugene | 1 |
| Handen, Benjamin L. | 1 |
| Hardan, Antonio Y. | 1 |
| Hollway, Jill A. | 1 |
| Leone, Sarah | 1 |
| Lindsay, Ronald | 1 |
| Masty, Jessica | 1 |
| Nash, Patricia | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkAman, Michael G.; Hollway, Jill A.; Leone, Sarah; Masty, Jessica; Lindsay, Ronald; Nash, Patricia; Arnold, L. Eugene – Research in Developmental Disabilities: A Multidisciplinary Journal, 2009
This study was designed to explore the placebo-controlled effects of risperidone on cognitive-motor processes, dyskinetic movements, and behavior in children receiving maintenance risperidone therapy. Sixteen children aged 4-14 years with disruptive behavior were randomly assigned to drug order in a crossover study of risperidone and placebo for 2…
Descriptors: Metabolism, Behavior Problems, Reaction Time, Hyperactivity
Handen, Benjamin L.; Hardan, Antonio Y. – Journal of the American Academy of Child & Adolescent Psychiatry, 2006
Objective: Olanzapine, an atypical antipsychotic, has been shown to be efficacious for treatment of psychotic and mood disorders in adults. This prospective, open-label study was conducted to examine the safety and usefulness of olanzapine in treating disruptive behavior disorders in adolescents with subaverage intelligence. Method: Sixteen…
Descriptors: Check Lists, Intelligence, Safety, Moderate Mental Retardation
